Stephanie Dusaban Gonzales

Stephanie Dusaban Gonzales

Goodwin

Contact
View Bio
RSS

Latest Posts › Biocon

Share:

Biocon Announces FDA Approval of Ustekinumab Biosimilar

On December 1, 2024, Biocon announced that the FDA has approved YESINTEK™ (ustekinumab-kfce), a biosimilar to J&J’s STELARA®. ...more

12/9/2024  /  Biocon , FDA Approval , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs

Recent Biosimilar Approvals By the FDA

Approval of Accord’s Trastuzumab Biosimilar: On September 18, 2024, Accord announced that the Food and Drug Administration (FDA) approved a 420 mg dosage of HERCESSI (trastuzumab-strf), a biosimilar to Genentech’s HERCEPTIN...more

9/30/2024  /  Amgen , Biocon , Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Genentech , Mylan Pharmaceuticals , Pharmaceutical Industry , Prescription Drugs , Sandoz
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide